Resmed Overview
Resmed Target Price
Analysts' 12-month price predictions for RMD.
Share Price
$256.21
Average Target Price
$266.25
3.9% upside
3.9% upside4 analysts in the last 4 months
High: $286 | Low: $240
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-20 | Morgan StanleyDavid Bailey | $286 | 11.6% upside |  |
| 2025-04-24 | KeyBancBrett Fishbin | $274 | 6.9% upside | |
| 2025-04-16 | Mizuho SecuritiesAnthony Petrone | $265 | 3.4% upside | |
| 2025-03-05 | Stifel Nicolaus | $240 |  6.3% downside | |
| 2025-01-31 | Piper SandlerAdam Maeder | $260 | 1.5% upside | |
| 2024-12-12 | Stifel NicolausJonathan Block | $250 | 2.4% downside | |
| 2024-10-01 | RBC CapitalCraig Wong-Pan | $224 | 12.6% downside | |
| 2024-09-23 | Robert W. BairdJoe Vruwink | $280 | 9.3% upside | |
| 2024-09-18 | Wolfe ResearchMike Polark | $180 | 29.7% downside | |
| 2024-04-10 | RBC CapitalCraig Wong-Pan | $187 | 27% downside | |
| 2024-04-01 | Stifel NicolausMike Matson | $224 | 12.6% downside | |
| 2023-10-27 | OppenheimerSuraj Kalia | $175 | 31.7% downside | |
| 2023-09-06 | NeedhamMike Matson | $180 | 29.7% downside | |
| 2022-06-20 | RBC CapitalCraig Wong-Pan | $244 | 4.8% downside | |
| 2022-04-29 | RBC Capital | $233 | 9.1% downside | |
| 2021-10-14 | OppenheimerSuraj Kalia | $312 | 21.8% upside | |
| 2021-08-04 | Morgan StanleySean Laaman | $250 | 2.4% downside | |
| 2021-07-28 | JefferiesAnthony Petrone | $240 | 6.3% downside | |